Skip to main content
SpringerLink
Log in

Vascular and Platelet Eicosanoids, Smoking and Atherosclerosis

  • Chapter
Tobacco Smoking and Atherosclerosis

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 273))

Abstract

Vascular tissue synthesizes prostanoids (PGs) that modulate contractility, myocyte and fibroblast proliferation, platelet aggregation and leucocyte function, all of which are key components in the pathophysiology of atherogenesis. Furthermore, platelet and leucocyte release substances have been shown to stimulate the synthesis and release of PGs from vascular cells. It is possible, therefore, that vascular PGs are part of a protective response against atherogenic events. Consequently, any disruption of PG synthesis (viz. as a result of smoking) may accelerate the atherogenic state. Although smoking is a major risk factor in the development of atherosclerosis, the combination of smoking with other risk factor (e.g., diabetes, hypertension, hypercholesterolaemia) markedly increases the likelihood of death from atherosclerotic disease. The present paper therefore discusses the following:

  1. 1)

    How PGs relate to pathophysiology of atherosclerosis

  2. 2)

    Experimental findings on the effects of cigarette smoking on vascular and platelet prostanoid synthesis.

  3. 3)

    How other risk factors may interact with smoking to influence vascular permeability

  4. 4)

    Future directions and emphases on research into eicosanoids and smoking.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. M.D. Haust, R.H. More and H.Z. Movat. The role of smooth muscle cells in the fibrogenesis of arteriosclerosis. Am. J. Pathol. 37: 377 (1960).

    PubMed  CAS  Google Scholar 

  2. R. Ross, J. Glomset and L. Harker. Response to injury and atherogenesis. Am. J. Pathol. 86: 675 (1977).

    PubMed  CAS  Google Scholar 

  3. R. Ross and J.A. Glomset. The pathogenesis of atherosclerosis: an update. N. Engl. J. Med. 314: 488 (1977).

    Article  Google Scholar 

  4. R.G. Gerrity. The role of monocytes in atherosclerosis. I Transition of blood borne monocytes into foam cells in fatty lesions. Am. J. Pathol. 103: 181 (1981).

    PubMed  CAS  Google Scholar 

  5. M.J. Mitchinson and R.Y. Ball. Macrophages and atherogenesis. Lancet 2: 146 (1987).

    Article  PubMed  CAS  Google Scholar 

  6. P. Hadhazy, B. Malomvolgyi and K. Magyar. Endogenous prostanoids and arterial contractility. Prostagl. Leuk. Essential Fatty Acids Revs. 32: 175 (1988).

    Article  CAS  Google Scholar 

  7. V. Tsang, J.Y. Jeremy, D.P. Mikhailidis, R.K. Walesby, J.V. Wright and P. Dandona. The release of prostacyclin by the human aorta. Cardiovasc. Res. 22: 489 (1988).

    Article  PubMed  CAS  Google Scholar 

  8. S. Moncada, A. Herman, E.A. Higgs and J.R. Vane. Differential formation of prostacyclin (PGX or PGI2) by layers of the arterial wall. An explanation for the antithrombotic properties of vascular endothelium. Thromb. Res. 11: 323 (1977).

    Article  PubMed  CAS  Google Scholar 

  9. N.L. Baenzinger, M.J. Dillender and P.W. Majerus. Cultured human fibroblasts and arterial cells produce a labile platelet-inhibitory prostaglandin. Biochem. Biophys. Res. Commun. 78: 294 (1977).

    Article  Google Scholar 

  10. J.Y. Jeremy and P. Dandona. Effect of endothelium removal on stimulatory and inhibitory modulation of vascular prostacyclin synthesis. Br. J. Pharmacol. 96: 243 (1989).

    PubMed  CAS  Google Scholar 

  11. J.Y. Jeremy, D.P. Mikhailidis and P. Dandona. Adrenergic modulation of vascular prostacyclin synthesis. Eur. J. Pharmacol. 114: 133 (1985).

    Article  Google Scholar 

  12. S.R. Coughlin, M.A. Moskowitz, H.N. Antoniades and L. Levine. Serotonin receptor-mediated stimulation of bovine smooth muscle cell prostacyclin synthesis and its modulation by platelet derived growth factor. Proc. Natl. Acad. Sci. 78: 7134 (1981).

    Article  PubMed  CAS  Google Scholar 

  13. N.L. Baezinger, F.J. Fogerty, L.F. Mertz and L.F. Chernuta. Regulation of histamine-mediated prostacyclin synthesis in cultured human vascular endothelial cells. Cell. 24: 915 (1981).

    Article  Google Scholar 

  14. J.Y. Jeremy and P. Dandona. The role of the diacycl glycerol protein kinase C system in mediating adrenoceptor-prostacyclin synthesis coupling in the rat aorta. Eur. J. Pharmacol. 136: 311 (1987).

    Article  PubMed  CAS  Google Scholar 

  15. J.Y. Jeremy and P. Dandona. Fluoride stimulates vascular prostacyclin synthesis: interrelationship of G proteins and protein kinase C. Eur. J. Pharmacol. 146: 279 (1988).

    Article  PubMed  CAS  Google Scholar 

  16. J.Y. Jeremy, D.P. Mikhailidis and P. Dandona. Excitatory receptorprostanoid synthesis coupling in smooth muscle: mediation by calcium protein kinase C and G proteins. Prostagl. Leuk. Essential Fatty Acids Revs. 34: 215 (1988).

    CAS  Google Scholar 

  17. S. Moncada and J.R. Vane. Prostacyclin formation and effects. In Chemistry, Biology and Pharmacological activity of prostanoids. (S.M. Roberts and F. Scheinmann, eds.). Pergamon Press. p. 258 (1979).

    Google Scholar 

  18. J.J. Huttner, E.T. Gwebu, R.V. Panganamala, G.E. Milo and D.B. Cornwell. Fatty acids and their prostaglandin derivatives: inhibitors of proliferation in aortic smooth muscle cells. Science. 197: 289 (1977).

    Article  PubMed  CAS  Google Scholar 

  19. H.D. Peters, B.A. Peskar and P.S. Schonhofer. Influence of prostaglandins on connective tissue cell growth and function. Naunyn Schmiedeberg’s Arch Pharmacol. 297: 587 (1977).

    Google Scholar 

  20. N. Owen. Prostacyclin can inhibit DNA synthesis in vascular smooth muscle cells. In Prostaglandins, leukotrienes and lipoxins. Biochemistry mechanisms of action and clinical applications. New York: Plenum Press. P. 193 (1985).

    Google Scholar 

  21. J. Nilsson and A.G. Olsson. Prostaglandin E1 inhibits DNA synthesis in arterial smooth muscle cells stimulated with platelet derived growth factor. Atherosclerosis 53: 77 (1984).

    Article  PubMed  CAS  Google Scholar 

  22. P. Libby, S.J.C. Warner and G.B. Friedman. Interleukin 1: a mitogen for human vascular smooth muscle cells that induces the release of growth inhibitory prostanoids. J. Clin. Invest. 81: 487 (1988).

    Article  PubMed  CAS  Google Scholar 

  23. K.B. Pomerantz and D.P. Hajjar. Eicosanoids in regulation of arterial smooth muscle cell phenotype, proliferative capacity and cholesterol metabolism. Arteriosclerosis. 9: 413 (1989).

    Article  PubMed  CAS  Google Scholar 

  24. B.B. Weksler, J.M. Knapp and E.A. Jaffe. Prostacyclin (PGI2) synthesized by cultured endothelial cells modulates polymorphonuclear leucocyte functions. Blood (Suppl 1): 287 (1977).

    Google Scholar 

  25. W. McClatchney and R. Snyderman. Prostaglandin and inflammation: enhancement of monocyte chemotactic responsiveness by prostaglandin E2. Prostaglandins 12: 415 (1976).

    Article  Google Scholar 

  26. R.B. Zurier. Prostaglandins and inflammation. In Prostaglandins. Biology and Chemistry of Prostaglandins and Related Eicosanoids. (P.B. Curtis, ed.) Churchill Livingstone, Edinburgh. p. 595 (1988).

    Google Scholar 

  27. J.Y. Jeremy, D.P. Mikhailidis, P. Dandona. The thromboxane A2 analogue U46619 stimulates vascular prostacyclin synthesis. Eur. J. Pharmacol. 107: 259 (1985).

    Article  PubMed  CAS  Google Scholar 

  28. A. Van Coevorden and J.M. Boeynaems. Physiological concentrations of ADP stimulate the release of prostacyclin from bovine endothelial cells. Prostaglandins 27: 615 (1984).

    Article  PubMed  Google Scholar 

  29. S.T. Test and N.U. Bang. Platelet activating factor stimulates prostacyclin synthesis by cultured human endothelial cells. Thromb. Haemostas. 46: 269 (1981).

    Google Scholar 

  30. S.R. Coughlin, M.A. Moskowits, B.R. Zetter, H.N. Antoniades and L. Levine. Platelet dependent stimulation of prostacyclin synthesis by platelet derived growth factor. Nature 288: 600 (1980).

    Article  PubMed  CAS  Google Scholar 

  31. V.R. Rossi, P. Breviario, E. Ghezzi, E. Dejana and A. Mantovani. Prostacyclin synthesis induced in vascular cells by interleukin-1. Science. 299: 174 (1985).

    Article  Google Scholar 

  32. CR. Albrightson, N.L. Baenziger, and P. Needleman. Exaggerated human vascular cell prostaglandin biosynthesis mediated by monocytes: role of monokines and interleukin 1. J. Immunol. 135: 1872 (1985).

    PubMed  CAS  Google Scholar 

  33. C.W. Benjamin, N.K. Hopkins, T.D. Oglesby and R.R. Gorman. Agonist specific desensitisation of leukotriene C4-stimulated PGI2 biosynthesis in human endothelial cells. Biochem. Biophys. Res. Comm. 117: 780 (1983).

    Article  PubMed  CAS  Google Scholar 

  34. Pittilo R.M., Machie I.J., Rowles P.M., MacLinn S.J. and Woolf N. Effects of cigarette smoking on the ultrastructure of rat thoracic aorta and its ability to produce prostacyclin. Thromb. Haemostas. 48: 173 (1982).

    CAS  Google Scholar 

  35. K. Asmussen and K. Kjeldsen. Intimal ultrastructure of human umbilical arteries. Observations on arteries from newborn children of smoking and non-smoking mothers. Circ. Res. 36: 570 (1975).

    Google Scholar 

  36. J.L. Nadler, J.S. Velasco and R. Horton. Cigarette smoking inhibits prostacyclin formation. Lancet 1: 1248 (1983).

    Article  PubMed  CAS  Google Scholar 

  37. C.H. Dadak, C.H. Leithner, H. Sinzinger and H. Silbergauer. Diminished prostacyclin formation in umbilical arteries born to women who smoke. Lancet 1: 94 (1981).

    Article  PubMed  CAS  Google Scholar 

  38. J. Reinders, H. Brinkman, J. Van Mourik and P. De Groot. Cigarette smoke impairs endothelial cell prostacyclin production. Arteriosclerosis. 6: 15 (1986).

    Article  PubMed  CAS  Google Scholar 

  39. H.A. Bull, R.M. Pittilo, N. Woolf and S.J. Machin. The effect of nicotine on human endothelial cell release of prostaglandins and ultrastructure. Br. J. Exp. Pathol. 69: 413 (1988).

    PubMed  CAS  Google Scholar 

  40. A. Wennmalm and P. Alster. Nicotine inhibits vascular prostacyclin but not platelet thromboxane A2 synthesis. Gen. Pharmacol. 14: 189 (1983).

    PubMed  CAS  Google Scholar 

  41. T. Sonnefeld and A. Wennmalm. Inhibition by nicotine of the foundation of prostacyclin-like activity in rabbit and human vascular tissue. Br. J. Pharmacol. 71: 609 (1980).

    Google Scholar 

  42. J.Y. Jeremy, D.P. Mikhailidis and P. Dandona. Cigarette smoke extracts but not nicotine inhibit prostacyclin (PGI2) synthesis in human, rabbit and rat vascular tissue. Prostagl. Leuk. Med. 19: 261 (1985).

    Article  CAS  Google Scholar 

  43. O. Ylikkorkola, L. Vinikka and P. Lehtovirta. Effects of nicotine on fetal prostacyclin and thromboxane in humans. Obstet. Gynecol. 66: 102 (1985).

    Google Scholar 

  44. J.Y. Jeremy, D.P. Mikhailidis and P. Dandona. Muscarinic stimulation of rat tracheal prostanoid synthesis: studies on the effects of calcium corticosteroids and cigarette smoke. Eur. J. Pharmacol. 162: 117 (1989).

    Google Scholar 

  45. J. Larruye, D. Daret, J. Demond-Henri, C. Aliieres and H. Bricaud. Prostacyclin synthesis in proliferative aortic smooth muscle cells. A kinetic in vivo and in vitro study. Atherosclerosis. 50: 63 (1984).

    Article  Google Scholar 

  46. L. Wilhelmsen. Coronary heart disease: epidemiology of smoking. Am. Heart J. 115: 242 (1985).

    Article  Google Scholar 

  47. T.W. Meade, M.V. Vickers, S.G. Thompson, Y. Stirling, A.P. Haines and G.J. Miller. Epidemiological characteristics of platelet aggregability. Br. Med. J. 290: 428 (1985).

    Article  CAS  Google Scholar 

  48. R.M. Jones. Smoking before surgery: the case for stopping. Br. Med. J. 290: 1763 (1985).

    Article  CAS  Google Scholar 

  49. A. Rosengren, L. Welin, A. Tsipogianni and L. Wilhelmsen. Impact of cardiovascular risk factors on coronary heart disease and mortality among middle aged diabetic men: a general population study. Br. Med. J. 299: 1127 (1989).

    Article  CAS  Google Scholar 

  50. J.Y. Jeremy, C.S. Thompson, D.P. Mikhailidis and P. Dandona. The effect of cigarette smoke and diabetes mellitus on muscarinic stimulation of prostacyclin synthesis by the rat penis. Diab. Res. 3: 467 (1986).

    CAS  Google Scholar 

  51. H. Wey and M. Subbiah. 6-keto-PGF1α synthesis in diabetic rat aorta: effect of substrate concentration and cholesterol feeding. Proc. Soc. Exp. Biol. Med. 171: 251 (1982).

    PubMed  CAS  Google Scholar 

  52. E. Ernst, W. Koenig, A. Matrai, B. Filipiak, and J. Stieber. Blood rheology in healthy cigarette smokers. Results from the MONICA project, Augsburg. Arteriosclerosis 8: 385 (1988).

    Article  PubMed  CAS  Google Scholar 

  53. R. Aitchinson and N. Russell. Smoking-a major cause of polycthaemia. J. Roy. Soc. Med. 81: 89 (1988).

    Google Scholar 

  54. T.W. Meade, J. Imeson and Y. Sterling. Effects of changes in smoking and other characteristics on clotting factors and the risk of IHD. Lancet 2: 986 (1987).

    Article  PubMed  CAS  Google Scholar 

  55. G. Galea and R.J.L. Davidson. Haematological and haemorrheological changes associated with cigarette smoking. J. Clin. Pathol. 38: 978 (1985).

    Article  PubMed  CAS  Google Scholar 

  56. C.G. Caro, M.J. Lever, K.H. Parker and P.J. Fish. Effects of cigarette smoking on the pattern of arterial blood flow: possible insight into mechanisms underlying the development of arteriosclerosis. Lancet 2: 11 (1987).

    Article  PubMed  CAS  Google Scholar 

  57. D.P. Mikhailidis, M.A. Barradas, M.A. Maris, J.Y. Jeremy and P. Dandona. Fibrinogen mediated activation of platelet aggregation and thromboxane A2 release: pathological implications in vascular disease. J. Clin. Pathol. 38: 1166 (1985).

    Article  PubMed  CAS  Google Scholar 

  58. C.S. Brischetto, W.E. Connor, S.L. Sonnor and J.D. Matarazzol. Plasma lipid and lipoprotein profiles of cigarette smokers from randomly selected families: enhancement of hyperlipidaemia and depression of high density lipoprotein. Am. J. Cardiol. 52: 675 (1983).

    Article  PubMed  CAS  Google Scholar 

  59. D.P. Mikhailidis and M.A. Barradas. Haemostatic effects of lipid-lowering drugs. J. Drug Develop. 2: 69 (1989).

    Google Scholar 

  60. A. Kershbaum, R. Khorsandian, R.F. Caplan, S. Bellet and C.J. Feinberg. The role of catecholamine in the free fatty acid response to cigarette smoking. Circulation. 28: 52 (1983).

    Google Scholar 

  61. H. Takeda. H. Kishikawa, M. Shinoharta. Effect of alpha2 adrenoceptor antagonist on platelet activation during insulin-induced hypoglycaemia in type-2 (non-insulin dependent) diabetes mellitus. Diabetologia 31: 657 (1988).

    Article  PubMed  CAS  Google Scholar 

  62. D.P. Mikhailidis, A.M. Mikhailidis, M.A. Barradas and P. Dandona. Effect of non-esterified essential fatty acids on the stability of prostacyclin activity. Metabolism 32: 717 (1983).

    Article  PubMed  CAS  Google Scholar 

  63. J.Y. Jeremy, D.P. Mikhailidis and P. Dandona. Simulating the diabetic environment modifies in vitro vascular prostacyclin synthesis. Diabetes 32: 217 (1983).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Chemical Pathology and Human Metabolism, Royal Free Hospital and School of Medicine, University of London, Pond Street, London, NW3 2QG, UK

    J. Y. Jeremy & D. P. Mikhailidis

Authors
  1. J. Y. Jeremy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. P. Mikhailidis
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Tobacco and Health Research Institute, University of Kentucky, Lexington, Kentucky, USA

    John N. Diana

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Plenum Press, New York

About this chapter

Cite this chapter

Jeremy, J.Y., Mikhailidis, D.P. (1990). Vascular and Platelet Eicosanoids, Smoking and Atherosclerosis. In: Diana, J.N. (eds) Tobacco Smoking and Atherosclerosis. Advances in Experimental Medicine and Biology, vol 273. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5829-9_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-5829-9_14

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-5831-2

  • Online ISBN: 978-1-4684-5829-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation